Kalaris Therapeutics, Inc.: which funds bought and sold
Institutions that bought and sold Kalaris Therapeutics shares in Q2 2026, from the holdings they reported to the SEC on Form 13F for March 31, 2026 and June 30, 2026.
Between March 31, 2026 and June 30, 2026, 28 institutions that filed 13F reports for both quarters added to or opened positions in Kalaris Therapeutics, and 20 cut or closed them. Together they sold a net 678K shares, −3.6% on what they held at the start of the quarter. Active managers and hedge funds on our list were net buyers of 183K shares (+7.3%); index fund managers were net buyers of 229K shares (+50.2%). 10 opened a new position and 12 sold out entirely.
Bought, Q2 2026 28 institutions, 10 of them new holders Sold, Q2 2026 20 institutions, 12 of them sold out
Net change, all compared −678K shares (−3.6%)
Net change, active managers +183K shares (+7.3%), 6 bought, 6 sold
Buyers versus sellers
28 bought 20 20 sold
Active managers and hedge funds 6 bought · 6 sold · +183K
Index fund managers 5 bought · 0 sold · +229K
Other institutions 17 bought · 14 sold · −1.1M
Biggest buyers
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| UBS Group AG | +256K +4138.9% | 262K | $1.1M |
| Vanguard Capital Management LLC Index funds | +143K +56.1% | 399K | $1.6M |
| Citadel Advisors LLC Hedge fund | +96K New position | 96K | $389,792 |
| Renaissance Technologies LLC Hedge fund | +83K +125.8% | 149K | $607,859 |
| Verdad Advisers, LP | +80K New position | 80K | $326,809 |
| Marshall Wace, LLP Hedge fund | +71K +105.1% | 139K | $566,549 |
| Pale Fire Capital Se | +40K New position | 40K | $161,278 |
| Morgan Stanley | +34K +88.6% | 72K | $294,367 |
| Trexquant Investment LP Hedge fund | +30K New position | 30K | $121,030 |
| Vanguard Fiduciary Trust Co Index funds | +29K +80.2% | 66K | $269,349 |
| Geode Capital Management, LLC Index funds | +26K +30.3% | 114K | $464,287 |
| Blackrock, Inc. Index funds | +18K +51.0% | 54K | $221,580 |
| Quadrature Capital Ltd Hedge fund | +17K New position | 17K | $67,265 |
| Connor, Clark & Lunn Investment Management Ltd. | +16K +119.8% | 30K | $122,128 |
| Dimensional Fund Advisors LP | +16K New position | 16K | $64,991 |
| Northern Trust Corp Index funds | +11K +78.8% | 26K | $105,165 |
| Virtu Financial LLC | +11K New position | 11K | $44,000 |
| Sigma Planning Corp | +10K New position | 10K | $41,380 |
| Bridgeway Capital Management, LLC Active manager | +10K +44.4% | 33K | $132,275 |
| Stonepine Capital Management, LLC | +9,722 +47.7% | 30K | $122,597 |
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Citadel Advisors LLC Hedge fund | +96K New position | 96K | $389,792 |
| Renaissance Technologies LLC Hedge fund | +83K +125.8% | 149K | $607,859 |
| Marshall Wace, LLP Hedge fund | +71K +105.1% | 139K | $566,549 |
| Trexquant Investment LP Hedge fund | +30K New position | 30K | $121,030 |
| Quadrature Capital Ltd Hedge fund | +17K New position | 17K | $67,265 |
| Bridgeway Capital Management, LLC Active manager | +10K +44.4% | 33K | $132,275 |
Biggest sellers
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | −700K Sold out | 0 | — |
| Propel Bio Management, LLC | −296K Sold out | 0 | — |
| Kalehua Capital Management LLC | −271K Sold out | 0 | — |
| Goldman Sachs Group Inc | −94K −85.5% | 16K | $65,340 |
| Simplify Asset Management Inc. | −87K Sold out | 0 | — |
| Samsara Biocapital, LLC | −67K −0.5% | 12.9M | $52.4M |
| Millennium Management LLC Hedge fund | −60K Sold out | 0 | — |
| 683 Capital Management, LLC Hedge fund | −45K Sold out | 0 | — |
| Susquehanna International Group, LLP | −38K −73.0% | 14K | $57,879 |
| Raymond James Financial Inc | −22K −18.3% | 97K | $395,457 |
| Qube Research & Technologies Ltd Hedge fund | −11K Sold out | 0 | — |
| Johnson Financial Group, Inc. | −10K Sold out | 0 | — |
| Citigroup Inc | −8,703 Sold out | 0 | — |
| Two Sigma Investments, LP Hedge fund | −6,803 −22.2% | 24K | $97,057 |
| Barclays PLC | −4,977 −94.3% | 303 | $1,233 |
| Squarepoint Ops LLC Hedge fund | −998 −2.5% | 39K | $157,814 |
| BNP Paribas Financial Markets | −600 −92.0% | 52 | $212 |
| Fortitude Family Office, LLC | −114 Sold out | 0 | — |
| Royal Bank Of Canada | −91 Sold out | 0 | — |
| Federated Hermes, Inc. Active manager | −34 Sold out | 0 | — |
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Millennium Management LLC Hedge fund | −60K Sold out | 0 | — |
| 683 Capital Management, LLC Hedge fund | −45K Sold out | 0 | — |
| Qube Research & Technologies Ltd Hedge fund | −11K Sold out | 0 | — |
| Two Sigma Investments, LP Hedge fund | −6,803 −22.2% | 24K | $97,057 |
| Squarepoint Ops LLC Hedge fund | −998 −2.5% | 39K | $157,814 |
| Federated Hermes, Inc. Active manager | −34 Sold out | 0 | — |
New positions
| Institution | Shares | Value June 30, 2026 |
|---|---|---|
| Citadel Advisors LLCHedge fund | 96K | $389,792 |
| Verdad Advisers, LP | 80K | $326,809 |
| Pale Fire Capital Se | 40K | $161,278 |
| Trexquant Investment LPHedge fund | 30K | $121,030 |
| Quadrature Capital LtdHedge fund | 17K | $67,265 |
| Dimensional Fund Advisors LP | 16K | $64,991 |
| Virtu Financial LLC | 11K | $44,000 |
| Sigma Planning Corp | 10K | $41,380 |
| Integrated Wealth Concepts LLC | 5,000 | $20,350 |
| Caitong International Asset Management Co., Ltd | 7 | $28 |
Sold out
| Institution | Shares | Value March 31, 2026 |
|---|---|---|
| Paradigm Biocapital Advisors LP | 700K | $4M |
| Propel Bio Management, LLC | 296K | $1.7M |
| Kalehua Capital Management LLC | 271K | $1.6M |
| Simplify Asset Management Inc. | 87K | $504,448 |
| Millennium Management LLCHedge fund | 60K | $343,511 |
| 683 Capital Management, LLCHedge fund | 45K | $259,650 |
| Qube Research & Technologies LtdHedge fund | 11K | $64,064 |
| Johnson Financial Group, Inc. | 10K | $57,700 |
| Citigroup Inc | 8,703 | $50,216 |
| Royal Bank Of Canada | 91 | $1,000 |
Who holds the shares
- Institutions reporting
- 56
- Ten largest holders
- 92.1% of 13F-reported shares
- Index fund managers
- 3.8% of 13F-reported shares
- Active managers and hedge funds
- 15.0% of 13F-reported shares
| Type | Bought | Sold | New | Sold out | Net change in shares | Net % |
|---|---|---|---|---|---|---|
| Active managers and hedge funds | 6 | 6 | 3 | 4 | +183K | +7.3% |
| Index fund managers | 5 | 0 | 0 | 0 | +229K | +50.2% |
| Other institutions | 17 | 14 | 7 | 8 | −1.1M | −6.9% |
← Back to Kalaris Therapeutics, Inc. · Insiders · Politicians